首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Breast cancer management

缩写:

ISSN:1758-1923

e-ISSN:1758-1931

IF/分区:0.4/N/A

文章目录 更多期刊信息

共收录本刊相关文章索引16
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mark A Sak,Peter J Littrup,Neb Duric et al. Mark A Sak et al.
Breast density is one of the strongest predictors of breast cancer risk. Women with the densest breasts are 4 to 6 times more likely to develop cancer compared with those with the lowest densities. Breast density is generally assessed using...
Kimlin Tam Ashing,Aria M Miller,Eudora Mitchell et al. Kimlin Tam Ashing et al.
This paper will present the multiple roles and the impact of cancer advocates. The emerging literature provides evidence for the consideration and integration of African American BC survivors as advocates in practice, policy and research re...
Yong-Hun Lee,William P Schiemann Yong-Hun Lee
Transforming growth factor (TGF-β) is a multifunctional cytokine that plays essential roles in regulating mammary gland development, morphogenesis, differentiation, and involution. TGF-β also regulates mammary gland homeostasis and preven...
Kathryn A Martinez,Allison W Kurian,Sarah T Hawley et al. Kathryn A Martinez et al.
Helping patients to maximize their autonomy in breast cancer decision-making is an important aspect of patient-centered care. Shared decision-making is a strategy that aims to maximize patient autonomy by integrating the values and preferen...
Michael K O&#x;Connor Michael K O&#x;Connor
Screening mammography is recognized as an imperfect imaging tool that performs poorly in women with dense breast tissue - a limitation which has driven demand for supplemental screening techniques. One potential supplemental technique is mo...
Bridgette F Peake,Rita Nahta Bridgette F Peake
Despite the tremendous efficacy of trastuzumab against HER2-overexpressing metastatic breast cancers, a significant fraction of women demonstrate progressive disease during treatment. Multiple mechanisms have been proposed to mediate trastu...